These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21684204)

  • 1. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy.
    Ranasinghe I; Yeoh T; Yiannikas J
    Heart Lung Circ; 2011 Sep; 20(9):579-86. PubMed ID: 21684204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated hypertrophy of the basal ventricular septum: characteristics of patients with and without outflow tract obstruction.
    Ranasinghe I; Ayoub C; Cheruvu C; Freedman SB; Yiannikas J
    Int J Cardiol; 2014 May; 173(3):487-93. PubMed ID: 24698253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intraoperative diagnosis of dynamic left ventricular outflow tract obstruction using transesophageal echocardiography leads to the treatment with intravenous disopyramide.
    Ashidagawa M; Ohara M; Koide Y
    Anesth Analg; 2002 Feb; 94(2):310-2, table of contents. PubMed ID: 11812689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of an increased pressure gradient through the left ventricular outflow tract: a West Coast experience.
    Kobayashi S; Sakai Y; Taguchi I; Utsunomiya H; Shiota T
    J Echocardiogr; 2018 Mar; 16(1):34-41. PubMed ID: 28921420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
    Monda E; Lioncino M; Palmiero G; Franco F; Rubino M; Cirillo A; Verrillo F; Fusco A; Caiazza M; Mazzella M; Moscarella E; Dongiglio F; Sepe J; Pacileo G; Calabrò P; Limongelli G
    Int J Cardiol; 2022 May; 354():22-28. PubMed ID: 35278578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting.
    Sirak TE; Sherrid MV
    Chest; 2008 May; 133(5):1243-6. PubMed ID: 18460523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.
    Verlinden NJ; Coons JC
    Pharmacotherapy; 2015 Dec; 35(12):1164-72. PubMed ID: 26684556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic echocardiographic features of patients with latent left ventricular outflow tract obstruction without left ventricular hypertrophy.
    Semba H; Sawada H; Uejima T; Takeda N; Soma K; Abe H; Yamashita T; Nagai R
    Int Heart J; 2012; 53(4):230-3. PubMed ID: 22878800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of responsiveness to disopyramide in patients with hypertrophic cardiomyopathy.
    Habib M; Hoss S; Bruchal-Garbicz B; Chan RH; Rakowski H; Williams L; Adler A
    Int J Cardiol; 2019 Dec; 297():75-82. PubMed ID: 31615649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide.
    Haruki S; Minami Y; Suzuki A; Hagiwara N
    Heart Vessels; 2015 Sep; 30(5):604-10. PubMed ID: 24917414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: Results From A Multicenter Registry.
    Santoro F; Ieva R; Ferraretti A; Fanelli M; Musaico F; Tarantino N; Martino LD; Gennaro LD; Caldarola P; Biase MD; Brunetti ND
    Cardiovasc Ther; 2016 Jun; 34(3):161-6. PubMed ID: 26946520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse geometric changes related to dynamic left ventricular outflow tract obstruction without overt hypertrophic cardiomyopathy.
    Cha JJ; Chung H; Yoon YW; Yoon JH; Kim JY; Min PK; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Cardiovasc Ultrasound; 2014 Jul; 12():23. PubMed ID: 24993692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in medical treatment of hypertrophic cardiomyopathy.
    Hamada M; Ikeda S; Shigematsu Y
    J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
    Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
    Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise.
    Cabrera-Bueno F; García-Pinilla JM; Gómez-Doblas JJ; Montiel-Trujillo A; Rodríguez-Bailón I; de Teresa-Galván E
    Int J Cardiol; 2007 Apr; 117(2):222-6. PubMed ID: 16844244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestation of Latent Left Ventricular Outflow Tract Obstruction in the Acute Phase of Takotsubo Cardiomyopathy.
    Ozaki K; Okubo T; Tanaka K; Hosaka Y; Tsuchida K; Takahashi K; Oda H; Minamino T
    Intern Med; 2016; 55(23):3413-3420. PubMed ID: 27904102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction.
    Balik M; Novotny A; Suk D; Matousek V; Maly M; Brozek T; Tavazzi G
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):685-688. PubMed ID: 32488425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Verheyen N; Batzner A; Zach D; Zirlik A; Gerull B; Frantz S; Maack C; Störk S; Seggewiss H; Morbach C
    Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):710-718. PubMed ID: 36841935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.